2015 Discharge: Innovative Medicines Initiative (IMI)

This procedure concerns the European Parliament's approval of the way the Joint Undertaking - Innovative Medicines Initiative (IMI) managed its budget in 2015. It's a key part of ensuring accountability and transparency in EU spending.

This decision affects the IMI and its partners, confirming the sound financial management of public funds allocated to the initiative.